By transfecting the full-length cDNA for human von Willebrand factor (vWf) into a line of Chinese hamster ovary cells with a defect in carbohydrate metabolism, we have prepared recombinant vWf specifically lacking 0-linked carbohydrates. We have compared this under-glycosylated protein to fully glycosylated recombinant vWf with respect to several structural and binding properties. vWf deficient in 0-linked glycans was synthesized, assembled into multimers, and secreted in an apparently normal manner and was not prone to degradation in the extracellular milieu. It did not differ from fully glycosylated vWf in ability to bind to heparin or to collagen type I but did interact less well with glycoprotein lb on formalin-fixed platelets. This decreased interaction was evidenced in both a lessened overall binding to platelets and in diminished capacity to promote platelet agglutination, in the presence of ristocetin. In contrast, no difference was seen in platelet binding in the presence of botrocetin. These data indicate a possible role for 0-linked carbohydrates in the vWf-glycoprotein lb interaction promoted by ristocetin and suggest that abnormalities in carbohydrate modification might contribute to the altered ristocetindependent reactivity between vWf and platelets described for some variant forms of von Willebrand disease. (J. Clin. Invest. 1992Invest. . 90:2258Invest. -2267
Introduction
von Willebrand factor (vWf)' is a large adhesive glycoprotein synthesized by endothelial cells and megakaryocytes, which is found in endothelial cells, platelets, plasma, and the subendothelial matrix as an array of high molecular weight multimers. There are two critical biological functions ofvWf. First, it binds noncovalently to and stabilizes clotting Factor VIIIC, the protein that is defective or lacking in hemophilia A. Second, vWf, through its ability to bind strongly to components in the subendothelium and to surface receptors on platelets, initiates plate-let plug formation at the site of an injury to the blood vessel wall (for review see reference 1). Quantitative or qualitative defects in the vWf protein result in a form of the prevalent human bleeding disorder, von Willebrand disease (vWd) (for review see reference 2).
In the endothelial cell, vWf is synthesized as a pre-pro-protein in the rough endoplasmic reticulum, where it undergoes core N-glycosylation and forms dimers through disulfide bond formation within the COOH-terminal regions of pairs of provWf subunits (3) . These prodimers are subsequently transported to the Golgi apparatus, where N-linked carbohydrates are processed and sulfated and 0-linked carbohydrates are added to each subunit (4, 5) . The prodimers are then assembled, via disulfide bonds within the NH2-terminal regions of the mature subunits, into a population of multimers containing up to 50 individual vWfsubunits (6) (7) (8) . Although the 741-amino acid propeptide of vWf is required for multimerization, it is not necessary for the functioning of vWf multimers and generally is cleaved from the 2,050-amino acid mature subunit (9, 10) . Noncovalently bound dimers ofvWfpropeptide circulate in plasma; their biological functions are presently unknown ( ll, 12) .
The N-terminal region of the mature vWf subunit is not only involved in multimerization but also contains several binding sites essential to the normal physiological functioning of vWf. Within the initial 728 amino acids of the mature subunit are the binding sites for Factor VIIIC, for the extracellular matrix components heparin and collagen type I, and for the platelet glycoprotein lb (GP lb) (13) (14) (15) (16) . vWf must interact strongly with components of the subendothelium and with the platelet surface to mediate platelet attachment and spreading and subsequently to maintain a platelet plug under the high shear stress created by flowing blood. Therefore, an abnormality in the binding between vWf and one of these components (whether due to the vWf itself or to the other protein) might result in a bleeding disorder. This is the case, for example, in Bernard-Soulier syndrome, where GP lb is absent (17) and therefore the initial interaction between vWf and platelets cannot occur. It has also been shown that vWfofpatients with type IIB vWd can bind spontaneously to platelets, with consequent depletion of both circulating platelets and of the larger, more reactive multimers of plasma vWf ( 18) .
The structural determinants of vWf participating in the interactions with platelet GP lb and extracellular matrix components are therefore ofgreat interest. Recently, several aspects of the binding sites within the region comprised by amino acids 449-728 ofthe mature subunit ofvWfhave been further delin- ,Mg/ml streptomycin, and 5% fetal bovine serum, at 370C in a humidified 5% C02:95% air incubator. After stable transfection, cells were cultured in the same medium containing 125 gg/ml G-418. Normal human umbilical vein endothelial cells (EC), elaborating native vWfwere used as a positive control in some experiments and were cultured as previously described (6) .
To (5) . For some experiments, the polyclonal antibody employed in the ELISA assay was employed for immunoprecipitation whereas for other experiments, the monoclonal antibody 2.2.9, covalently coupled to Sepharose, or a mixture of these, was employed. A-42 and EC were similarly treated.
Binding assays
The media of A-16 cells were collected for 48 h as described and was concentrated 10-fold. vWf protein levels were determined by ELISA so that equivalent amounts of each were employed. Typical vWf levels were between 0.5 and 1 ,g/ml.
Heparin binding. Aliquots of concentrated 0-or 0+ collection media were incubated with Sepharose beads containing or lacking immobilized heparin, in 50 mM Tris-buffered saline (TBS) pH 7.4 containing 1% BSA (TBS-BSA), for 30 min with rocking, at room temperature ( 14). The unbound supernatant was removed, and the beads were washed and then eluted with TBS-BSA containing concentrations of NaCl < 0.5 M. All fractions were then assayed by ELISA.
Collagen binding. Collagen binding was assayed by a modification of the procedure of Bockenstedt et al. (25) . An 11 mg/ml bovine type I acid-soluble collagen stock solution was diluted to 1.87 mg/ml in 20 mM sodium citrate buffer pH 6.1. This solution was used to coat the wells ofa microtiter plate for 90 min at 37°C. Subsequently the wells were washed with 50 mM Tris buffer pH 7.4 plus 150 mM NaCl and were blocked with 0.1% BSA in that buffer for 60 min at room temperature. Dilutions of conditioned media containing 0-or O+ recombinant vWf were then added to the wells and the level of vWf bound to the collagen after a 60-min incubation at 37°C was determined with the rabbit anti-human vWf polyclonal antibody conjugated to horseradish peroxidase, as described for the ELISA assay.
GP lb binding. To assay ristocetin-dependent binding of vWf to platelets, aliquots of 0-or O+ collection media were incubated in TBS with Formalin-fixed human platelets in TBS at 1 X 108/ml, final concentration in 400 Ml total volume. Ristocetin was added to the final concentrations noted. After rocking at room temperature for 30 min, the platelets were sedimented by centrifugation, and the levels ofvWfremaining in the supernatant were determined by ELISA. No spontaneous binding to platelets in the absence of ristocetin occurred with either sample. Assays with botrocetin were performed in a similar manner.
Platelet agglutination. 0-or 0+ culture media were concentrated as described above, and then aliquots of these samples were stirred at 37°C, along with Formalin-fixed human platelets at 1 x 108/ml, in a total volume of 400 Ml, in cuvettes of a dual-channel aggregometer (Sienco, Inc., Morrison, CO). The change in light transmittance through each sample was monitored after addition of ristocetin at the concentrations noted.
Western blotting
After electrophoresis, vWf protein from SDS-agarose gels was blotted to nitrocellulose paper by a 5-h transfer at 0.5 mA in 20 mM Tris, 150 mM glycine buffer pH 8.3 containing 20% (vol/ vol) methanol and 0.01% SDS in a transfer apparatus (Transphor; Hoefer Scientific Instruments). The blot was blocked in a solution of 5% Carnation® dry milk in PBS, and then incubated with anti-vWfpolyclonal antibody at 1:500 (vol/vol) in 10 mM Tris buffer pH 7.4 containing 150 mM NaCl and 4% BSA (wt/vol). After washing, the blot was incubated with detecting antibody (alkaline-phosphatase-conjugated goat antirabbit polyclonal antibody) and then developed with the colorimetric phosphatase substrates nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate.
Results
Characteristics ofIdl-D cells. ldl-D cells are a Chinese hamster ovary line that are severely deficient in UDP-galactose 4-epimerase and UDP-N-acetyl-galactosamine 4-epimerase activities (26) . Since these cells cannot interconvert UDP-glucose and UDP-galactose (UDP-Gal), or UDP-N-acetyl-glucosamine and UDP-N-acetyl-galactosamine (UDP-GalNAc), they consequently cannot incorporate either Gal or GalNAc into carbohydrate chains when provided with medium lacking these sugars. However, when Gal and/or GalNAc are provided in the culture medium, ldl-D cells take them up and convert them to UDP-Gal and UDP-GalNAc by salvage pathways. Because GalNAc is only rarely found in N-linked glycans but is the initial residue of the mucin-type 0-linked carbohydrate chains added to glycoproteins in the Golgi apparatus ofanimal cells (27) , the omission of GalNAc from the culture medium permits selective suppression of O-linked glycosylation. Gal is a common constituent of both N-linked and 0-linked glycans, therefore its inclusion in the culture medium when GalNAc is absent insures that N-linked carbohydrates will be processed normally. When both Gal and GalNAc supplement the culture medium, the synthesis of both the N-linked and O-linked carbohydrate chains of glycoproteins is unimpeded. cysteine-labeled samples from a similar experiment were analyzed on a discontinuous 1.5% SDS-agarose gel (Fig. 3) . A Western blot ofthis gel was done, and the multimer pattern of normal pooled human plasma, which was not immunoprecipitated before application to the gel, is shown in lane 1. Lanes 2 and 3 are the autoradiographs ofimmunoprecipitated samples of recombinant vWf with and without 0-linked glycans, respectively. Both the Western blot and its autoradiograph demonstrate the presence ofmultimers in recombinant vWf, whether fully glycosylated or deficient in O-glycans.
In this system as well, the difference in electrophoretic mobility of vWf with altered carbohydrate modifications was observed. The higher molecular weight multimers of vWf were assembled and secreted under conditions where O-glycosylation was not carried out. Since, unlike human umbilical vein EC, ldl-D cells do not have a regulated secretion pathway, the largest multimers are not as prevalent as those seen in the conditioned medium of EC or in plasma (references 3, 28; Fig. 3 ). However, multimers up to the 20-mer are detectable in the conditioned media of the ldl-D cells, regardless of whether 0-linked glycans are present. Migrating behind each major band are satellite multimers containing one or more subunits oflarge vWf. These data indicate that the absence of O-linked glycans does not adversely affect the process of vWf multimerization.
The data described above demonstrated that vWf without O-linked glycans was multimerized, processed by proteolytic removal of the propeptide, and constitutively secreted from A-16 cells. A lack of O-glycans interfered with translocation of at least one membrane glycoprotein, the gp55 ofthe IL-2 recep- (Fig. 4 A) . When the radioactive label in each band was quantitated using a blot analyzer (Beta Scope; Betagen, Waltham, MA), it was found that nearly equal amounts of radioactivity were present in the vWf bands immunoprecipitated before and after 5 d of incubation in the presence of the A-42 cells. Samples prepared similarly were immunoprecipitated with monoclonal anti-vWf antibody and analyzed by agarose gel electrophoresis (Fig. 4 B) . A full range of vWf multimers was recovered from both samples, and no leading satellites were observed in either. Thus, lack of 0-linked glycans does not seem to lead to proteolytic instability of vWf in the tissue culture environment.
Effects ofO-glycosylation on v Wfbindingandplatelet agglutination. Since 8 of the 10 O-linked glycosylation sites on the 2,050-amino acid mature vWf subunit are located within the region encompassing the heparin, collagen type I, and platelet GP lb binding sites, we investigated whether the O-linked carbohydrates might be functionally important to the binding between vWf and these proteins.
Both vWf with N-linked and O-linked glycans and vWf selectively lacking the O-linked glycans did bind to Sepharose beads that were chemically coupled to heparin (Fig. 5) but not to Sepharose beads alone (data not shown). These vWf samples were eluted from the heparin-Sepharose at the expected NaCl concentrations (0.20-0.25 M) (14). When assayed for ability to bind to collagen type I, again no discrepancy was seen between vWf samples possessing or lacking O-linked carbohydrates (data not shown).
In contrast, we observed that whereas vWf modified by 0-glycans bound to formalin-fixed human platelets at low concentrations of ristocetin, vWf without 0-glycans did not (Fig.  6 ). At higher ristocetin concentrations, the inability of the underglycosylated vWf to bind to platelets appeared to be partly overcome, although the observed binding was clearly less than that observed for the fully glycosylated vWf at the same concentration of ristocetin. There was negligible binding of either vWf sample to the platelets in the absence of ristocetin and negligible reaction between either vWf sample and ristoctin in the absence of platelets. The interaction between platelets and recombinant O+ vWfwas inhibitable by a monoclonal anti-GP lb antibody, suggesting that binding is via the GP lb receptor (unpublished results). Since equivalent amounts of vWf protein were used, and since the underglycosylated sample is not unstable or of a significantly different multimer distribution than the fully glycosylated sample, the lower binding could be attributed to a diminished interaction between this vWfsample and the platelet GP lb. However, we also examined the binding between 0-and O+ vWf and formalin-fixed platelets in the presence of botrocetin and found that this agent promoted the interaction regardless of the glycosylation state of the vWf (Fig. 7) .
To further analyze the interaction between these vWf samples and GP lb, we performed agglutination assays of 0-and 0+-conditioned media containing equivalent amounts of vWf with formalin-fixed human platelets and ristocetin at several different final concentrations (Fig. 8) . The vWf was capable of supporting agglutination of platelets both in the presence and the absence of O-glycans, but again the extent of the reaction was dependent upon the glycosylation state of the vWf. The agglutination was more extensive for O+ vWf than 0-vWf at each level of ristocetin. Thus, in terms of ability to support ristocetin-dependent agglutination, the vWf lacking O-linked glycans was also deficient in comparison to the vWf possessing 0-linked glycans. similar to that ofa denatured globular protein (31 ) . The 0-glycans, and in particular the initial GalNAc residues, are apparently responsible for maintaining the native structure. Similarly, in a study of recombinant human granulocyte colonystimulating factor, the presence of the single carbohydrate modification, an 0-glycan, was found necessary to maintain the native conformation and activity over a period of days (32). For the study of recombinant glycoproteins with more complex glycosylation patterns, a second experimental system has recently become available. This system uses ldl-D cells, with their bypassable deficiency ofUDP-galactose 4-epimerase and UDP-N-acetyl-galactosamine 4-epimerase activities. Using this system, it has been demonstrated that although two cell-surface glycoproteins, the low-density lipoprotein receptor (26) and the decay-accelerating factor (30) , are normally synthesized and transported, they are unstable in the extracellular milieu and are quickly degraded. Another surface glycoprotein, the gp55 of the IL-2 receptor (29) Previous studies of the influence of carbohydrate on the functions of human vWf used enzymatic treatments of the native protein and have shown that deglycosylation can induce both instability to proteases and alterations in adhesiveness.
vWf exhibits a complicated pattern of carbohydrate modification, with 12 N-linked glycans and 100 -linked glycans present on each mature subunit. 8 of the 100 -linked glycans are situated between residues 485-500 and 705-724, short regions of vWf protein backbone that are believed to be close together in the tertiary structure ( 19) residues 1,460 and 2,027 (4). Sialic acids and Gal are common constituents ofboth N-linked and 0-linked glycans, and in fact occur on at least some glycans isolated from human vWf ( 35, 36) . The enzymatic removal of these components will therefore introduce alterations in both classes of glycans, and at widely distributed sites. The removal of terminal sialic acids from the carbohydrate of vWf by treatment with neuraminidase increases sensitivity to proteolysis within the NH2-terminal region, whereas removal of both sialic acids and Gal by treatment with neuraminidase and 13-galactosidase induces greater sensitivity (37) . It has also been demonstrated that enzymatic desialation augments the adhesive interaction of vWf with the GP lb receptor of washed platelets (38) .
We have used the ldl-D system to address the role of 0-linked carbohydrate modifications to the properties of vWf (39) , such instability was not seen for vWf lacking 0-glycans.
The absence of 0-linked carbohydrates was without influ-ence on the binding between vWf and both collagen type I and heparin but did result in a decreased, not heightened, interaction with platelet GP lb when ristocetin was used as modulator. This effect was evidenced both as a lower overall binding to Formalin-fixed platelets and as a diminished ability of vWf to agglutinate the platelets at the lower concentrations of ristocetin tested. Because the 0-glycan-deficient vWf is stable, and its multimeric distribution appears identical to that of the fully glycosylated recombinant vWf, these observations seem directly attributable to the lack of O-linked glycans. Conversely, the presence ofcarbohydrates had no apparent influence on the interaction between vWf and GP lb induced by botrocetin. This observation must be examined with respect to the various differences between ristocetin (a glycopeptide produced by Nocardia lurida) and botrocetin (a glycoprotein factor from the venom of snakes of the genus Bothrops) as cofactors for platelet agglutination by soluble vWf. Ristocetin can cause the precipitation of protein, is more reactive with the larger multimers of vWf than with the smaller multimers, and is confined in reactivity to human platelets and vWf (40, 41) . Botrocetin, however, is not known to be a protein-precipitating agent, is reactive with all multimeric forms of vWf, and promotes aggregation with platelets and plasma from many mammalian sources (42) (43) (44) . Unlike ristocetin, botrocetin is active with vWf from patients with type IIA vWd (41) , which may have a lowered affinity for GP lb compared with native vWf (45) . The mechanisms of action by which these agents induce vWf-dependent platelet aggregation may differ as well. Ristocetin apparently binds to both the platelet and vWf (40) . However, it has been established that botrocetin reacts with the vWf to form a vWf-botrocetin complex, which subsequently interacts with platelet GP lb (46).
The same general region of vWf (extending from amino acid Val 449-Lys 728) is involved in binding to GP lb, whether that binding is induced by ristocetin or botrocetin. Proteolytic fragments of vWf that contain the entire region are reactive with platelets in the presence of either agent (16, 47) . Among the interesting features of this region (Fig. 1) is the disulfide bond between Cys 509 and Cys 695, which effectively segregates a region having a large proportion of positively charged residues (510-694) from one with few positively charged residues, which is extensively modified by carbohydrate chains, and therefore is expected to carry a strong negative charge (449-509 and 695-728) (48) . The importance of the disulfide-loop region and its overall positive charge to the interaction between vWf and GP lb has been shown recently by analyses of amino acid substitutions occurring in type IIB vWf (49, 50) . Four missense mutations have been reported within the disulfide-loop region; three of these involve the replacement of arginine residues with uncharged residues.
The intrachain disulfide loop may also contain the binding site for botrocetin. The dimeric proteolytic fragment IIIT2, generated by successive digestions ofvWfwith protease V8 and trypsin, which does not contain amino acid residues Leu 521 -Lys 673 (that is, most of the intrachain disulfide loop), also does not have reactivity with platelets in the presence ofbotrocetin (23) . Recently, it has been suggested that the botrocetinbinding site includes amino acid residues 539-553, 569-583, and 629-643 (51) .
With regard to ristocetin-vWf binding, an electrostatic mechanism has been proposed. Ristocetin is cationic and would be expected to interact with a region ofthe vWfhaving a net negative charge (52) . It has been suggested that dimeric ristocetin recognizes the amino acid sequence X-Pro-Gly-X. This sequence is found in many proteins that are precipitated by ristocetin (40 (54) have shown that the Val440-Asn730 fragment of vWf cDNA expressed in Escherichia coli can bind to washed platelets in the presence of 1 mg/ml ristocetin and that a synthetic peptide corresponding to amino acids 692-708 of vWf can inhibit this interaction. Our data suggest only that the 0-glycans of vWf have a positive influence upon the interaction with GP lb induced by ristocetin, whereas their absence diminishes the interaction. Desialation ofvWfpermits a spontaneous interaction with platelets and, presumably, desialation of the O-glycans contributes to this effect. However, our data suggest that the absence of entire O-glycans might significantly alter the local conformation ofthe protein so that it is no longer able to interact properly with either ristocetin or GP lb, or both. The data indicating that platelet binding in the presence of botrocetin is not affected by the glycosylation state of vWf also do not contradict prior observations, since the disulfide-loop region ofvWf, required for botrocetin reactivity, is not glycosylated.
At present, there is no clear association between the extent of carbohydrate modification of vWf, and vWd, which might be due to any of a diverse number of causes. In type I vWd, there is an overall decrease in the amount ofapparently normal vWf protein present in the plasma, although the entire spectrum of multimers is represented (2) . In type IIA vWd there is either proteolytic instability of the vWf multimers, especially the largest multimers, in the plasma (39) or a defect in vWf secretion (55) . However, bleeding abnormalities might also be occasioned by an aberration in the binding characteristics ofan apparently quantitatively and structurally normal vWfprotein.
For instance, in a variant form of vWd the bleeding disorder arises from a decreased binding between vWf and Factor VIIIC, attributable to a defect in the vWf protein (56, 57) . A similar mechanism was recently implicated in type IIB vWd, where the decrease in both circulating platelets and the larger vWf multimers from plasma is attributable to spontaneous binding between soluble vWfand platelets ( 18, 58) . It has been reported that type IIA vWf may have reduced affinity for GP lb as well (45 ) . It might be expected that any defect in vWfthat reduced the extent of the interaction with GP lb might also induce a clinically significant bleeding disorder. We have shown here that a lack ofO-linked carbohydrate modifications on vWf may be one such defect that hinders appropriate platelet agglutination.
It is not known at present whether the effect we have described is a cumulative response to the loss of several O-linked carbohydrates or whether it could result, for instance, from a point mutation causing the loss of a single key O-linked carbohydrate attachment site. 
